All News

FDA has approved Invokamet, a fixed-dose therapy combining canagliflozin and metformin HCl in a single tablet, to treat adults with type 2 diabetes, according to the maker of the drug.

GlaxoSmithKline (GSK) with its partner, the National Institute of Allergy and Infectious Diseases (NIAID), is expected to begin a phase 1 trial this fall on a potential vaccine for the treatment of Ebola virus, a deadly disease that has killed approximately 1,000 in a recent outbreak in West Africa, according to a report by Reuters.

Individuals who have a vitamin D deficiency have a higher risk of developing Alzheimer’s disease, according to a prospective, population-based study published online for Neurology, the journal of the American Academy of Neurology.

Accidents happen. Things go wrong. The unforeseen occurs. A crisis plan can keep a controlled threat from turning into a full-fledged disaster.

Over the last few years, the number of drugs on shortage has remained the same. It may even have gone up. Hospitals continue to confront the issues and devise responses.

Mallinckrodt Pharmaceuticals started formulating and supplying industry-leading pharmaceutical products more than 146 years ago. Continually building on its legacy, the company employs a vertically integrated process to ensure quality control during every step of the product’s development from active ingredient processing through formulation, manufacturing, and distribution.

Camber Pharmaceuticals

Camber Pharmaceuticals strives to be the most reliable and cost effective generic pharmaceutical supplier across a broad range of therapeutic classes.

When druggists morphed into pharmacists, an essential quality was lost. The need for speed has just about buried it. But you can bring it back.

Teva Generics

Teva Generics leads the U.S. generic pharmaceutical market in total and new prescriptions, with total prescriptions of approximately 523 million in 2013, representing one out of every seven generic prescriptions filled in the U.S.

Medicinal plants and drugs of biological origin have their place in the treatment of chronic diseases. Among them, stevia shows promise as a possible source of new therapies for diabetes.

Available technology can help pharmacies improve patient adherence, boost patient outcomes, and earn high CMS Star measures. Everybody wins.

Title II of the DQSA is the Drug Supply Chain Security Act. As of January 1, 2015, new changes and mandates will move all members of the supply chain closer to becoming mandatory oversight partners with FDA.